Top 5 Mid-Cap Stocks with Impressive Growth Potential in next five years

Investing in mid-cap stocks can be an exciting opportunity for those looking to balance the stability of large-cap companies with the growth potential of smaller, more agile firms. These medium-sized companies, typically valued between £1.5 billion and £7.5 billion, are often at a growth stage where they can expand rapidly. For this start of 2025, we have had a look on the following five mid-cap stocks that stand out for their impressive growth potential. We are reviewing a lot of growth stocks recently and running a couple of investment challenges for growth stocks and dividend stocks if you are interested in knowing more. For now, let’s continue with this post and explore these companies and what makes them attractive to investors, even if you’re new to the financial world.

1. Iovance Biotherapeutics (IOVA)

What does Iovance do?

Iovance Biotherapeutics is a biotechnology company specialising in cutting-edge cancer immunotherapy. The company focuses on developing tumour-infiltrating lymphocyte (TIL) therapies, which harness the body’s immune system to target and destroy cancer cells.

Why is it exciting?

Iovance is currently advancing its treatments through late-stage clinical trials, targeting melanoma and other types of cancer. If these therapies receive regulatory approval, they could revolutionise cancer treatment and open up a massive market for the company.

Growth Potential

• Estimated CAGR: 25-30% over the next five years.
• Key Drivers: Successful trial results and potential FDA approval for its TIL therapies could result in exponential revenue growth. This innovation positions Iovance as a leader in the lucrative oncology market.

Why should you care?

Cancer affects millions of people worldwide, and the demand for effective treatments is growing. Investing in Iovance could offer the opportunity to support a company working on life-changing therapies while potentially yielding high returns.

2. CRISPR Therapeutics (CRSP)

What does CRISPR Therapeutics do?

CRISPR Therapeutics is a pioneer in gene-editing technology. Using CRISPR-Cas9, the company develops treatments for genetic diseases such as sickle cell anaemia and beta-thalassemia.

Why is it exciting?

CRISPR’s gene-editing platform has the potential to cure previously untreatable genetic conditions. With ongoing clinical trials and collaboration with pharmaceutical giants, the company is at the forefront of a medical revolution.

Growth Potential

• Estimated CAGR: 30-35% over the next five years.
• Key Drivers: CRISPR is progressing toward regulatory approval for therapies like exa-cel, which could become a blockbuster treatment. Partnerships and licensing agreements also boost its financial prospects.

Why should you care?

Gene editing is not just a buzzword; it’s a game-changer in medicine. By investing in CRISPR Therapeutics, you’re not only supporting groundbreaking science but also tapping into a market with immense growth potential.

3. Viking Therapeutics (VKTX)

What does Viking Therapeutics do?

Viking Therapeutics is a biotechnology firm focusing on metabolic and endocrine disorders. One of its key areas of research is non-alcoholic steatohepatitis (NASH), a liver condition affecting millions globally.

Why is it exciting?

NASH currently lacks approved treatments, presenting a significant opportunity. Viking’s pipeline includes promising drugs that could capture a substantial share of this multi-billion-dollar market.

Growth Potential

• Estimated CAGR: 35-40% over the next five years.
• Key Drivers: Clinical success in NASH treatment and potential market entry by 2025-2026 are major growth catalysts. Positive trial results could propel Viking into a leading position in this niche.

Why should you care?

Health conditions like NASH are on the rise, creating a strong demand for effective treatments. Viking’s focus on addressing this unmet need positions it as an attractive growth stock for socially conscious investors.

4. Applied Digital (APLD)

What does Applied Digital do?

Applied Digital started as a company focused on Bitcoin mining but has since pivoted towards AI and cloud computing services. The company provides high-performance computing infrastructure for industries requiring intensive data processing.

Why is it exciting?

As artificial intelligence (AI) continues to reshape industries, the demand for specialised cloud computing services is skyrocketing. Applied Digital’s strategic shift positions it to capitalise on this trend.

Growth Potential

• Estimated CAGR: 45-50% over the next three to five years.
• Key Drivers: A 523% year-over-year growth in its cloud services revenue highlights the company’s successful transformation. Partnerships with major AI firms further strengthen its prospects.

Why should you care?

The AI revolution is here, and it’s only getting bigger. Applied Digital offers an opportunity to invest in the infrastructure powering this technological shift, with high growth potential.

5. Tidewater (TDW)

What does Tidewater do?

Tidewater operates the world’s largest fleet of offshore support vessels (OSVs), which are essential for oil and gas exploration and production.

Why is it exciting?

With growing global energy demands and a potential resurgence in offshore drilling, Tidewater’s services are becoming increasingly critical. The company’s modern fleet and global presence give it a competitive edge.

Growth Potential

• Estimated CAGR: 20-25% over the next five years.
• Key Drivers: Rising offshore drilling activity and demand for OSVs are key growth factors. Tidewater is also diversifying into renewable energy support services, adding another layer of potential.

Why should you care?

Energy remains a cornerstone of the global economy. Tidewater’s focus on both traditional and renewable energy sectors offers a balanced investment opportunity with room for growth.

Why mid-cap stocks for growth?

Investing in mid-cap stocks like these can be a rewarding way to diversify your portfolio. While companies like Iovance Biotherapeutics and CRISPR Therapeutics are driving breakthroughs in healthcare, others like Applied Digital are riding the AI wave, and Tidewater is leveraging its position in the evolving energy market.

These five companies are united by their impressive growth potential, making them attractive options for 2025 and beyond. Whether you’re new to investing or a seasoned investor, these stocks represent exciting opportunities to be part of transformative industries while aiming for substantial returns. Always remember to conduct thorough research or consult a financial advisor to ensure these investments align with your financial goals and risk tolerance.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always consult with a professional before making investment decisions.